Analysis of volatile organic compounds in rats with dopaminergic lesion: Possible application for early detection of Parkinson's disease

Neurochemistry International

Volumn 76, Issue , 2014, Pages 82-90

  Khatib, S ^a,b   Finberg, J P M ^c   Artoul, F ^a,b   Lavner, Y ^b   Mahmood, S ^a,b   Tisch, U ^c   Haick, H ^c   Aluf, Y ^a,c   Vaya, J ^a,b  

^a MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^b TEL HAI COLLEGE   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Biomarkers; Early detection; GC MS; Parkinson disease; SPME; VOCs

Indexed keywords

1 OCTEN 3 OL; 2 ETHYLHEXANOL; DIMETICONE; DIVINYLBENZENE; DOPAMINE; OXIDOPAMINE; VOLATILE ORGANIC COMPOUND;

ADSORPTION; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISEASE COURSE; DOPAMINERGIC SYSTEM; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; NORADRENERGIC NERVE; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SOLID PHASE MICROEXTRACTION; TISSUE HOMOGENATE; ANIMAL; EARLY DIAGNOSIS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; EARLY DIAGNOSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; VOLATILE ORGANIC COMPOUNDS;

EID: 84905176972     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.06.016     Document Type: Article

References (51)

1. S.S. Ahmed, W. Santosh, S. Kumar, and H.T. Christlet Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection J. Biomed. Sci. 16 2009 63
2. Y. Aluf, J. Vaya, S. Khatib, Y. Loboda, S. Kizhner, and J.P. Finberg Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule Free Radic. Res. 44 2010 635 644
3. D.L. Ashley, M.A. Bonin, F.L. Cardinali, J.M. McCraw, and J.V. Wooten Measurement of volatile organic compounds in human blood Environ. Health Perspect. 104 Suppl. 5 1996 871 877 (Pubitemid 26402324)
4. E. Bezard, C.E. Gross, and J.M. Brotchie Presymptomatic compensation in Parkinson's disease is not dopamine-mediated Trends Neurosci. 26 2003 215 221 (Pubitemid 36412004)
5. B.C. Blount, R.J. Kobelski, D.O. McElprang, D.L. Ashley, J.C. Morrow, D.M. Chambers, and F.L. Cardinali Quantification of 31 volatile organic compounds in whole blood using solid-phase microextraction and gas chromatography-mass spectrometry J. Chromatogr. B 832 2006 292 301 (Pubitemid 43339961)
6. M. Bogdanov, W.R. Matson, L. Wang, T. Matson, R. Saunders-Pullman, S.S. Bressman, and M. Flint Beal Metabolomic profiling to develop blood biomarkers for Parkinson's disease Brain 131 2008 389 396 (Pubitemid 351197614)
7. H. Braak, J.R. Bohl, C.M. Muller, U. Rub, R.A. de Vos, and K. Del Tredici Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered Mov. Disord. 21 2006 2042 2051 (Pubitemid 46140410)
8. J. Brotchie, and C. Fitzer-Attas Mechanisms compensating for dopamine loss in early Parkinson disease Neurology 72 2009 S32 38
9. E. Combet, J. Henderson, D.C. Eastwood, and K.S. Burton Influence of sporophore development, damage, storage, and tissue specificity on the enzymic formation of volatiles in mushrooms (Agaricus bisporus) J. Agric. Food Chem. 57 2009 3709 3717
10. A. Cork, and K.C. Park Identification of electrophysiologically-active compounds for the malaria mosquito, Anopheles gambiae, in human sweat extracts Med. Vet. Entomol. 10 1996 269 276 (Pubitemid 27108491)
11. M.C. de Rijk, L.J. Launer, K. Berger, M.M. Breteler, J.F. Dartigues, M. Baldereschi, L. Fratiglioni, A. Lobo, J. Martinez-Lage, C. Trenkwalder, and A. Hofman Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group Neurology 54 2000 S21 23
12. C. Deng, N. Li, and X. Zhang Development of headspace solid-phase microextraction with on-fiber derivatization for determination of hexanal and heptanal in human blood J. Chromatogr. B 813 2004 47 52 (Pubitemid 39535427)
13. C. Deng, X. Zhang, and N. Li Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry J. Chromatogr. B 808 2004 269 277 (Pubitemid 38952922)
14. J.P. Finberg, Z. Gluzman, M. Reshef, Y. Loboda, U. Mohsen, T. Bressler-Stramer, R. Miari, L. Gepstein, S. Marom, and Y. Feld Modulation of excessive neuronal activity by fibroblasts: potential use in treatment of Parkinson's disease Restor. Neurol. Neurosci. 28 2010 803 815
15. C.E. Garner, S. Smith, B. de Lacy Costello, P. White, R. Spencer, C.S. Probert, and N.M. Ratcliffe Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease FASEB J. 21 2007 1675 1688 (Pubitemid 46855613)
16. A.K. Gottzein, F. Musshoff, and B. Madea Qualitative screening for volatile organic compounds in human blood using solid-phase microextraction and gas chromatography-mass spectrometry J. Mass Spectrom. 45 2010 391 397
17. N. Greenberg, A. Grassano, M. Thambisetty, S. Lovestone, and C. Legido-Quigley A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease Electrophoresis 30 2009 1235 1239
18. R. Guadagni, N. Miraglia, A. Simonelli, A. Silvestre, M. Lamberti, D. Feola, A. Acampora, and N. Sannolo Solid-phase microextraction-gas chromatography-mass spectrometry method validation for the determination of endogenous substances: urinary hexanal and heptanal as lung tumor biomarkers Anal. Chim. Acta 701 2011 29 36
19. M. Hakim, S. Billan, U. Tisch, G. Peng, I. Dvrokind, O. Marom, R. Abdah-Bortnyak, A. Kuten, and H. Haick Diagnosis of head-and-neck cancer from exhaled breath Br. J. Cancer 104 2011 1649 1655
20. A.A. Inamdar, M.M. Hossain, A.I. Bernstein, G.W. Miller, J.R. Richardson, and J.W. Bennett Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration Proc. Natl. Acad. Sci. USA 110 2013 19561 19566
21. A.A. Inamdar, P. Masurekar, and J.W. Bennett Neurotoxicity of fungal volatile organic compounds in Drosophila melanogaster Toxicol. Sci. 117 2010 418 426
22. A.A. Inamdar, P. Masurekar, M. Hossain, J.R. Richardson, and J.W. Bennett Signaling pathways involved in 1-octen-3-ol-mediated neurotoxicity in Drosophila melanogaster: implication in Parkinson's disease Neurotox. Res. 25 2014 183 191
23. R. Ionescu, Y. Broza, H. Shaltieli, D. Sadeh, Y. Zilberman, X. Feng, L. Glass-Marmor, I. Lejbkowicz, K. Mullen, A. Miller, and H. Haick Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes ACS Chem. Neurosci. 2 2011 687 693
24. K.A. Jellinger Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts Mov. Disord. 27 2012 8 30
25. M. Kusano, E. Mendez, and K.G. Furton Development of headspace SPME method for analysis of volatile organic compounds present in human biological specimens Anal. Bioanal. Chem. 400 2011 1817 1826
26. S.J. Lee, and K.G. Lee Inhibitory effects of volatile antioxidants found in various beans on malonaldehyde formation in horse blood plasma Food Chem. Toxicol. 43 2005 515 520
27. J. Liu, K. Hara, S. Kashimura, M. Kashiwagi, T. Hamanaka, A. Miyoshi, and M. Kageura Headspace solid-phase microextraction and gas chromatographic-mass spectrometric screening for volatile hydrocarbons in blood J. Chromatogr. B 748 2000 401 406
28. K.G. Lloyd CNS compensation to dopamine neuron loss in Parkinson's disease Adv. Exp. Med. Biol. 90 1977 255 266
29. A.M. Lozano, and S.K. Kalia New movement in Parkinson's Sci. Am. 293 2005 68 75 (Pubitemid 40920763)
30. A.W. Michell, D. Mosedale, D.J. Grainger, and R.A. Barker Metabolomic analysis of urine and serum in Parkinson's disease Metabolomics 4 2008 191 201
31. B. Mollenhauer, J.J. Locascio, W. Schulz-Schaeffer, F. Sixel-Doring, C. Trenkwalder, and M.G. Schlossmacher Alpha-synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study Lancet Neurol. 10 2011 230 240
32. G. Ouyang, and J. Pawliszyn A critical review in calibration methods for solid-phase microextraction Anal. Chim. Acta 627 2008 184 197
33. G. Peng, M. Hakim, Y.Y. Broza, S. Billan, R. Abdah-Bortnyak, A. Kuten, U. Tisch, and H. Haick Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors Br. J. Cancer 103 2010 542 551
34. G. Peng, U. Tisch, O. Adams, M. Hakim, N. Shehada, Y.Y. Broza, S. Billan, R. Abdah-Bortnyak, A. Kuten, and H. Haick Diagnosing lung cancer in exhaled breath using gold nanoparticles Nat. Nanotechnol. 4 2009 669 673
35. D. Poli, M. Goldoni, M. Corradi, O. Acampa, P. Carbognani, E. Internullo, A. Casalini, and A. Mutti Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS J. Chromatogr. B 878 2010 2643 2651
36. J.K. Qiang, Y.C. Wong, A. Siderowf, H.I. Hurtig, S.X. Xie, V.M. Lee, J.Q. Trojanowski, D. Yearout, J. BLeverenz, T.J. Montine, M. Stern, S. Mendick, D. Jennings, C. Zabetian, K. Marek, and A.S. Chen-Plotkin Plasma apolipoprotein A1 as a biomarker for Parkinson disease Ann. Neurol. 74 2013 119 127
37. M.P. Quinones, and R. Kaddurah-Daouk Metabolomics tools for identifying biomarkers for neuropsychiatric diseases Neurobiol. Dis. 35 2009 165 176
38. T. Senger, T. Wichard, S. Kunze, C. Gobel, J. Lerchl, G. Pohnert, and I. Feussner A multifunctional lipoxygenase with fatty acid hydroperoxide cleaving activity from the moss Physcomitrella patens J. Biol. Chem. 280 2005 7588 7596 (Pubitemid 40349651)
39. S. Sharma, C.S. Moon, A. Khogali, A. Haidous, A. Chabenne, C. Ojo, M. Jelebinkov, Y. Kurdi, and M. Ebadi Biomarkers in Parkinson's disease (recent update) Neurochem. Int. 63 2013 201 229
40. M. Shirasu, and K. Touhara The scent of disease: volatile organic compounds of the human body related to disease and disorder J. Biochem. 150 2011 257 266
41. G. Shuster, Z. Gallimidi, A.H. Reiss, E. Dovgolevsky, S. Billan, R. Abdah-Bortnyak, A. Kuten, A. Engel, A. Shiban, U. Tisch, and H. Haick Classification of breast cancer precursors through exhaled breath Breast Cancer Res. Treat. 126 2011 791 796
42. A. Siderowf, S.X. Xie, H. Hurtig, D. Weintraub, J. Duda, A. Chen-Plotkin, L.M. Shaw, V. Van Deerlin, J.Q. Trojanowski, and C. Clark CSF amyloid beta 1-42 predicts cognitive decline in Parkinson disease Neurology 75 2010 1055 1061
43. U. Tisch, Y. Aluf, R. Ionescu, M. Nakhleh, R. Bassal, N. Axelrod, D. Robertman, Y. Tessler, J.P. Finberg, and H. Haick Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors ACS Chem. Neurosci. 3 2012 161 166
44. U. Tisch, I. Schlesinger, R. Ionescu, M. Nassar, N. Axelrod, D. Robertman, Y. Tessler, F. Azar, A. Marmur, J. Aharon-Peretz, and H. Haick Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors Nanomedicine (Lond.) 8 2013 43 56
45. R.T. Tremblay, D. Kim, and J.W. Fisher Determination of tissue to blood partition coefficients for nonvolatile herbicides, insecticides, and fungicides using negligible depletion solid-phase microextraction (nd-SPME) and ultrafiltration J. Toxicol. Environ. Health A 75 2012 288 298
46. M. van Aardt, S.E. Duncan, J.E. Marcy, T.E. Long, S.F. O'Keefe, and S.R. Nielsen-Sims Aroma analysis of light-exposed milk stored with and without natural and synthetic antioxidants J. Dairy Sci. 88 2005 881 890 (Pubitemid 41431287)
47. W.D. van de Berg, D.H. Hepp, A.A. Dijkstra, J.A. Rozemuller, H.W. Berendse, and E. Foncke Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease Parkinsonism Relat. Disord. 18 Suppl. 1 2012 S28 30
48. E.S. Wang, H.B. Yao, Y.H. Chen, G. Wang, W.W. Gao, Y.R. Sun, J.G. Guo, J.W. Hu, C.C. Jiang, and J. Hu Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients pre- and post-deep brain stimulation Cell. Physiol. Biochem. 31 2013 625 637
49. M.G. Weisskopf, E. O'Reilly, H. Chen, M.A. Schwarzschild, and A. Ascherio Plasma urate and risk of Parkinson's disease Am. J. Epidemiol. 166 2007 561 567 (Pubitemid 47283643)
50. A. Wright Willis, B.A. Evanoff, M. Lian, S.R. Criswell, and B.A. Racette Geographic and ethnic variation in Parkinson disease: a population-based study of US medicare beneficiaries Neuroepidemiology 34 2010 143 151
51. R. Xue, L. Dong, S. Zhang, C. Deng, T. Liu, J. Wang, and X. Shen Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry Rapid Commun. Mass Spectrom. 22 2008 1181 1186 (Pubitemid 351600767)